Cardiovascular Disease Risk Factors Among Women Veterans at VA Medical Facilities by unknown
Cardiovascular Disease Risk Factors Among Women Veterans
at VA Medical Facilities
Varsha G. Vimalananda, MD, MPH1,2, Donald R. Miller, ScD1,3, Cindy L. Christiansen, PhD1,3,
Wenyu Wang, MS1, Patricia Tremblay, MMS1, and B. Graeme Fincke, MD1,3
1Center for Health Quality, Outcomes and Economic Research (CHQOER), Edith Nourse Rogers Memorial VA Medical Center, Bedford, MA, USA;
2Department of Medicine, Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston, MA, USA; 3Department
of Health Policy and Management, Boston University School of Public Health, Boston, MA, USA.
BACKGROUND: Hypertension, hyperlipidemia, diabe-
tes, and obesity in middle adulthood each elevate the
long-term risk of cardiovascular disease (CVD). The
prevalence of these conditions among women veterans
is incompletely described.
OBJECTIVE: To describe the prevalence of CVD risk
factors among women veterans in middle adulthood.
DESIGN: Serial cross-sectional studies of data from the
Diabetes Epidemiologic Cohorts (DEpiC), a national,
longitudinal data set including information on all
patients in the Veterans Health Administration (VA).
PARTICIPANTS: Women veterans (n=255,891) and
men veterans (n=2,271,605) aged 35–64 receiving VA
care in fiscal year (FY) 2010.
MAIN MEASURES: Prevalence of CVD risk factors in
FY2010 by age and, for those aged 45–54 years, by race,
region, period of military service, priority status, and
mental illness or substance abuse; prevalence by year
from 2000 to 2010 in women veterans receiving VA care
in both 2000 and 2010 who were free of the factor in
2000.
KEY RESULTS: Hypertension, hyperlipidemia, and
diabetes were common among women and men, al-
though more so among men. Hypertension was present
in 13 % of women aged 35–44 years, 28 % of women
aged 45–54, and 42 % of women aged 55–64. Hyperlip-
idemia prevalence was similar. Diabetes affected 4 % of
women aged 35–44, and increased more than four-fold
in prevalence to 18 % by age 55–64. The prevalence of
obesity increased from 14 % to 18 % with age among
women and was similarly prevalent in men. The relative
rate of having two or more CVD risk factors in women
compared to men increased progressively with age, from
0.55 (35–44 years) to 0.71 (45–54) to 0.73 (55–64). Most
of the women with a factor present in 2010 were first
diagnosed with the condition in the 10 years between
2000 and 2010.
CONCLUSIONS: CVD risk factors are common among
women veterans aged 35–64. Future research should
investigate which interventions would most effectively
reduce risk in this population.
KEY WORDS: women; veterans; epidemiology; cardiovascular disease;
risk factors.
J Gen Intern Med 28(Suppl 2):S517–23
DOI: 10.1007/s11606-013-2381-9
© Society of General Internal Medicine 2013
INTRODUCTION
Cardiovascular disease (CVD) remains the leading cause
of death among women and men in the United States.1
The presence of even one major CVD risk factor at age
50 years substantially raises the lifetime risk of CVD,
and is associated with lower survival in the general
population.2 Veterans of military service receiving care
from the Veterans Health Administration (VA) may be at
even higher risk of CVD than the general population.
since they often have poorer health status and more
medical conditions.3,4 In addition, veteran patients have
higher rates of mental illnesses such as depression and
PTSD, which are associated with increased CVD risk.5,6
Women represent a growing segment of the veteran
population that has not been fully characterized with
respect to CVD risk.7,8 As compared to men, women
veterans carry a similar burden of overall physical and
mental health conditions, but are of lower mean age and
have less social support.9 Previous studies indicate a high
prevalence of CVD risk factors among adult women in
the general population (hypertension, 29 %;10 hyperlip-
idemia, 42 %;11 diabetes, 8 %;12 and obesity, 36 %13).
Understanding the pattern of CVD risk factors among
women veterans can inform efforts to ultimately prevent
or delay the onset of CVD in this group.
The objectives of the present study were to describe
the prevalence of CVD risk factors in women veterans
of middle adulthood in fiscal year (FY) 2010 receiving
VA care, to examine how the distribution of these risk
factors varies by various demographic factors, mental
illnesses, and substance abuse, and to describe changes
in the prevalence of each risk factor from FY2000 to
FY2010 among women who were free of that condition
in FY2000. For reference, we present prevalence data
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for men veterans receiving VA care alongside that of
women.
METHODS
We conducted serial cross-sectional studies using data
from the VA Diabetes Epidemiology Cohort (DEpiC), a
national, longitudinal data set including information on all
patients in the VA since 1998. DEpiC is constructed from
multiple national computerized data files in the VA, and
includes information on medical encounters, prescriptions,
laboratory tests, mortality, Medicare claims data for VA
patients, and VA patient survey data.14 We included all
veterans aged 35–64 years who were receiving healthcare
from the VA in fiscal year (FY) 2010 and had at least two
services in the 24-month period of FY 2009–2010.
Demographic characteristics included age, race, region,
period of military service, priority status, and healthcare
utilization. Race data in DEpiC combines information from
VA records, Medicare claims, and the 1999 Large Health
Survey of Veteran Enrollees,15 with preferential use of self-
reported measures; race was still missing for many patients (see
Table 1). We assigned patients to one of four US census regions
based on the location of the care facility where they had the
most visits in FY 2010. Patients were classified by period of
military service (Vietnam War era and before; post-Vietnam
era; Persian Gulf War/Operation Enduring Freedom (OEF)/
Operation Iraqi Freedom (OIF); and other, which includes a
mix of unknown and active service). Priority status is a measure
of a veteran’s eligibility for VA services that we used as a proxy
for economic and disability status. Priority status was grouped
into four categories: full disability (no co-pay for prescriptions
and visits: priority groups 1 and 4); poverty (no co-pay: priority
group 5); part disability (variable co-pay: priority groups 2, 3, 6
and 9) and co-pay (priority groups 7 and 8, with neither
disability nor poverty). Healthcare utilization was defined by
the number of outpatient visits in the year, and by whether an
individual had any inpatient service during the year.
Prevalence rates were estimated as the percent of those in
the sample who were classified as having the condition in
the year. Each clinical condition was identified on the basis
of at least 2 days with ICD-9-CM codes recorded from
inpatient or outpatient medical encounters in the 24-month
period of FY2009–2010. Diabetes also was assigned if the
patient was dispensed a diabetes medication in FY2010.14
Codes and medications used to identify the conditions are
listed in online Appendix 1. Obesity was identified solely
on the basis of ICD-9-CM codes, because sufficient
measures of height and weight were not available for the
study time periods. We considered hypertension, hyperlip-
idemia, diabetes, and obesity to be CVD risk factors. In our
prior work, we found that only 6 % of VA patients with
diabetes would not be identified with use of VA data
alone.14 We therefore found it likely that VA patients with
an index CVD condition would have come to the VA for
care and had that condition documented.
Women and men were stratified by decade of age in
FY2010: 35–44; 45–54; and 55–64 years. For each group,
we calculated frequencies for demographic and clinical
characteristics in FY2010. For the veterans aged 45–
54 years, we present prevalence of CVD risk factors by
category of race, region, period of military service, priority
status, and presence of mental health conditions and
substance abuse. For each age group, we calculated the
relative rate of having 2+ CVD risk factors in women
compared to men by dividing the rate of each condition in
women by that in men. For example, in age group 35–44
the relative rate was 11 %÷20 %=55 %.
To establish fixed cohorts and examine the emergence
of CVD risk factors over a 10-year period, the overall
sample of veterans, aged 35–64 years, receiving health-
care from the VA in FY2010 (with at least two services
in the 24-month period of FY2009–2010) was limited to
those who also received care from the VA in FY2000
(with at least two services in the 24-month period of
FY1999–2000). Conditions in earlier years were identi-
fied using the same methods described above for
FY2010. In this sample, we calculated prevalence of
CVD risk factors in FY2010 and in FY2000. Then, in
women without the factor in FY2000 (35–44 year: N=
17,934; 45–54 year: N=38,479; 55–64 year: N=35,703),
we calculated the cumulative annual incidence of the
factor in FY2001 as the proportion of those with the
factor during that year from among those without it in
the prior year. This was added to the baseline prevalence
from FY2000 to obtain an estimate of period prevalence
for FY2000–2001. This process was repeated for each
year between FY2000 and FY2010, calculating incidence
proportion for each year in those without the factor in
prior years, and adding it to the period prevalence from
the prior year. This provided running period prevalences
for those years, which we present as smoothed plots.
Though we did not require that patients receive VA care
in every year from FY2000 through FY2010, 67 % of
women and 75 % of men in our sample did receive VA
care continuously during this period, and the plots
derived in the sample of patients with continuous service
use were similar.
Statistical analyses were performed using SAS version
9.2 (SAS Institute Inc, Cary, North Carolina). Institutional
review board approval was obtained from the Bedford VA
Medical Center Institutional Review Board.
RESULTS
Our sample included 255,891 women and 2,271,605 men
aged 35–64 years (Table 1). Across age groups, women
were more commonly Black, living in the South, and
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diagnosed with major depression, bipolar disorder, or
anxiety disorder, whereas men were more often hospital-
ized, used tobacco, and carried a diagnosis of schizophre-
nia, alcohol abuse, or substance abuse.
The prevalence of hypertension, hyperlipidemia, and
diabetes was high in both women and men, although each
was more common among men (Fig. 1). Hypertension and
hyperlipidemia were more common than diabetes, while all
three conditions increased in frequency with increasing age.
Hypertension was present in 13 % of women aged 35–
44 years, 28 % of women aged 45–54, and 42 % of women
aged 55–64. Hyperlipidemia was very similar in prevalence.
Diabetes affected 4 % of women aged 35–44, but increased
more than four-fold by age 55–64 to a prevalence of 18 %.
Obesity followed a different pattern. It was diagnosed more
commonly among women and the prevalence increased less
with age – from 14 % to 18 % in women and from 14 % to
17 % in men. The prevalence of women with 2+ risk factors
increased from 11 % to 24 % to 38 % with age, and among
men it increased from 20 % to 34 % to 52 %. The relative
rate of having two or more CVD risk factors in women as
compared to men also increased progressively, from 0.55
(35–44 years) to 0.71 (45–54) to 0.73 (55–64).
Prevalence of CVD risk factors among 45–54 year old
women and men VA patients showed variation by race,
region, priority status and mental health condition (Table 2).
Among race groups, Blacks had the highest prevalence of
hypertension (women 45 %; men 50 %) and the lowest
prevalence of hyperlipidemia (women 28 %; men 35 %).
Among both women and men, whites had the lowest
prevalence of diabetes as well as lower prevalence of
obesity compared to Blacks or Hispanics. Those with full
disability as a basis for VA eligibility (priority status) had
the highest prevalence of all conditions compared to those
with other priority status. Among those with mental illness,
diabetes was most common among those with schizophre-
nia (women 24 %; men 25 %). While the overall prevalence
of obesity among women 45–54 years old was 17 %
(Fig. 1), the prevalence of obesity among women of this age
group with schizophrenia was more than doubled at 36 %.
Of women 45–54 years old with depression, 38 % had
hypertension, 40 % had hyperlipidemia, 14 % had diabetes,
and 25 % were obese.
While Fig. 1 displays the prevalence of CVD risk factors
among women in FY2010, Fig. 2 displays the prevalence of
disease in FY2000, as well as the increase in risk factor
Table 1. Demographic and Clinical Characteristics of Women and Men Veterans Aged 35–64 Years in 2010*
35–44 years 45–54 years 55–64 years
Women Men Women Men Women Men
(n=66,976) (n=278,752) (n=105,075) (n=572,678) (n=83,840) (n=1,420,175)
Race†
White 54 64 59 60 70 75
Black 37 26 34 31 22 17
Hispanic 5 6 4 5 4 4
Other 5 4 4 4 4 3
Region
Northeast 12 12 13 12 14 13
South 51 46 50 46 46 43
Midwest 17 20 18 20 18 22
West 20 22 20 21 23 22
Period of military service
Vietnam War era and before 0 0 5 15 35 89
Post-Vietnam War era 14 19 40 53 16 5
Persian Gulf War/OEF/OIF‡ 66 75 33 29 15 5
Other 20 6 22 3 35 1
Priority status§
Full disability 22 21 23 19 19 21
Poverty 16 18 22 27 26 21
Part disability 54 53 47 45 44 47
Co-pay 7 8 8 10 11 11
Healthcare utilization
Outpatient visit in the year (mean±SD) 12±16 11±17 14±20 15±22 14±18 15±19
Any inpatient visit in the year 6 7 7 11 7 11
Mental illness/Substance abuse
Major depression 27 22 28 23 26 21
Bipolar disorder 7 6 7 6 5 3
Anxiety disorder 12 10 11 9 10 7
Post-traumatic stress disorder 13 15 13 8 9 17
Schizophrenia 1 2 2 4 2 3
Alcohol or substance abuse 6 13 8 20 5 13
Tobacco use 10 15 17 24 14 22
*All values are % unless otherwise specified
†Missing values for race are: Age 35–44 W 25 %, M 17 %; Age 45–54 W 23 %, M 13 %; Age 55–64 W 23 %; Men 12 % ‡OEF/OIF=Operation
Enduring Freedom/Operation Iraqi Freedom
§Missing values for priority status are: Age 35–44 W 4 %, M 4 %; Age 45–54 W 4 %, M 2 %; Age 55–64 W 3 %; Men 2 %
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prevalence from FY2000–FY2010 among women who
were free of each condition in FY2000, stratified by age in
FY2010. Most of the women with a factor present in 2010
developed the condition in the 10 years between 2000 and
2010. The prevalence of each condition increased substantial-
ly across the decade in all age groups, with increases of more
than five-fold in rates in several categories. In some cases, the
secular trend (increase over time) exceeded the increase with
age. This was particularly striking for obesity. We found that
the prevalence of obesity in FY2010 among the cohort who
was 45–54 in that year was much higher than the prevalence in
the older cohort when they were that age (in FY2000),
suggesting an earlier emergence of disease among the younger
cohort. Large increases over time were found for the other risk
factors, but also with substantial increases across the age
groups.
DISCUSSION
We demonstrate that women veterans have high rates of
CVD risk factors. While men have a higher prevalence of
hypertension, hyperlipidemia, and diabetes, the gap in
overall risk factor burden narrows with increasing age.
About one-quarter of women veterans in VA have more
than two CVD risk factors at age 45–54 years; this increases
to over one-third in women aged 55–64 years. Given the
strong association of CVD risk factors in mid-adulthood
with increased long-term CVD risk,2 the synergistic risk
posed by the presence of more than one risk factor,16 and
the increasing numbers of women serving in the military,
these findings portend a significant future burden of CVD
among women veterans receiving care in the VA. Therefore,
interventions to reduce CVD risk among veterans should be
designed with both women and men in mind.
An overview of CVD risk factors among women veterans
has heretofore been lacking. Using ICD-9 codes, Yoon et al.
reported that hypertension was the most commonly diag-
nosed condition among all woman veteran VA patients in
2008 (206.7/1000).7 Diabetes was diagnosed in 86.3/1000.
We found a higher prevalence of both conditions, but our
study is limited to women of middle adulthood, which
eliminates younger women who would have a low
prevalence by virtue of their age. In addition, Yoon et al.
ascertained diagnoses on the basis of two ICD-9 codes in a
single fiscal year. We used a 2-year time period to identify
codes, which would capture more patients, and by including
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Figure 1. Prevalence of CVD risk factors in women and men veterans aged 35–64 years in 2010.
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diabetes.14 Most other reports of CVD risk factor preva-
lence among veterans do not stratify results by sex,17,18 but
we demonstrate that hypertension, hyperlipidemia, and
diabetes are less common among women, while obesity is
similarly prevalent between sexes. A prior study of obesity
prevalence in the VA using height and weight data from
clinical encounters found more obesity among women than
men,19 which supports our finding that the gender distribu-
tion of obesity is different from that of hypertension,
hyperlipidemia or diabetes.
Cardiovascular disease risk reduction presents a significant
challenge to the healthcare system. Diet and exercise are
effective methods of weight loss to prevent or delay CVD and
diabetes, but behavior change interventions, such as those of
the Diabetes Prevention Program, are resource-intensive and
difficult to sustain at the local level.20 The effectiveness of
such interventions is also critically dependent on how they are
implemented.21 For those who have already developed risk
factors, adherence to medication is as important as lifestyle
modification. However, a Cochrane review of interventions to
improve adherence found that even the most effective methods
of promoting adherence to medications for chronic conditions
showed only modest improvements.22 A novel intervention
utilizing storytelling to promote behavior change demonstrat-
ed reductions in blood pressure among inner-city African
Americans that were comparable or better than many other
behavioral and pharmacologic interventions.23 Whether this
strategy could be equally effective for other chronic conditions
in other populations, including veteran women and men, has
yet to be confirmed.
The question remains as to whether any interventions to
reduce CVD risk should be different for women and men.We
did not examine the modifying effects of depression or other
patient characteristics on the incidence of CVD risk factors,
which may be very different between women and men.
Women also have sex-specific barriers to behavior change
and adherence, such as their inaccurately low perception of
CVD risk,24 as well as significant childcare and eldercare
responsibilities.25 Certain aspects of healthcare content and
delivery are valued differently by women and men,26,27 and
women-tailored primary care is associated with higher
satisfaction among women veterans.28 Therefore, there are
several potential reasons to develop sex-specific CVD risk
reduction interventions that remain incompletely explored.
Our study has several limitations. Use of ICD-9-CM
codes may underestimate the true prevalence of disease.29
Although our use of two diagnoses within a 2-year period is
a highly sensitive method of detecting hyperlipidemia and
diabetes, and is supported by other studies,14,29,30 it is likely
that obesity rates were underestimated. The previously cited
Table 2. Cardiovascular Disease (CVD) Risk Factors by Race, Region, Period of Military Service, Priority Status and Mental Illness/
Substance Abuse for Women and Men Veterans Aged 45–54 Years in 2010*
Total Hypertension Hyperlipidemia Diabetes Obesity
Women Men Women Men Women Men Women Men Women Men
Total (N) 105,075 572,678 29,372 237,888 29,220 225,922 10,767 100,582 17,605 88,119
Race
White 47,498 298,345 26 40 35 43 10 17 18 16
Black 27,291 155,611 45 50 28 35 15 20 22 15
Hispanic 2,904 26,210 26 41 36 47 13 24 22 21
Other 3,259 18,271 31 42 33 42 15 22 18 15
Region
Northeast 13,235 70,787 22 38 26 41 9 16 18 19
South 52,244 264,462 32 45 29 41 11 18 17 15
Midwest 18,402 114,409 27 42 30 42 10 18 17 15
West 21,194 123,020 23 36 24 34 9 16 15 14
Period of military service
Vietnam war and before 4,830 85,233 39 48 40 41 17 22 22 16
Post- Vietnam war era 42,145 305,333 34 43 33 39 13 19 21 16
Persian Gulf/OEF/OIF‡ 34,556 167,189 29 38 29 41 9 14 18 15
Other 23,544 14,923 13 15 14 16 5 6 7 6
Priority status
Full disability 23,017 103,448 32 45 33 45 12 20 20 18
Poverty 22,478 151,894 28 41 25 35 11 18 16 14
Part disability 48,189 250,482 27 42 27 41 10 17 16 16
Co-pay 8,549 53,198 27 41 28 41 10 18 16 15
Mental illness/Substance abuse
Major depression 29,247 129,992 38 49 40 47 14 21 25 20
Bipolar disorder 7,853 36,193 35 46 40 46 16 20 27 20
Anxiety disorder 12,080 50,620 37 48 40 48 13 17 24 18
Post traumatic stress disorder 13,157 48,214 35 47 38 46 14 18 26 19
Schizo- phrenia 2,333 22,050 42 47 41 45 24 25 36 21
Alcohol, substance abuse 8,598 111,823 40 47 34 36 12 16 20 14
Tobacco cessation treatment 17,542 138,642 39 48 45 46 13 18 21 16
*Prevalence of CVD risk factors is expressed as the percent of women and men in each demographic group who have factor
‡OEF/OIF = Operation Enduring Freedom/Operation Iraqi Freedom.
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study using height and weight data from clinical encounters
found higher obesity rates of approximately 30 %,19 which
calls into question the accuracy of provider coding practices
around obesity. There were high rates of missing race data
and women had higher rates of missing data than men in
each age cohort. The limitations of race data in the VA are
well-documented,31 but we are not aware of a basis for
a sex difference in these limitations. We did not use
data on fee-basis care for hypertension, hyperlipidemia,
and obesity in each year of the study, as we have found
it to be less reliable and complete than other VA
utilization data. However, we did conduct a sensitivity
analysis using 2010 fee-basis data to assess the degree
to which we might be missing prevalent conditions. We
found that for both sexes, addition of fee-basis data in
2010 would add a similar percent of cases, but that
these new cases would comprise less than 0.025 % of
the overall sample for each condition. Patients with a
condition at any time were not included in the
denominator in subsequent years, as our focus was on
calculating annual incidence of CVD risk factors. Fluctuations
in obesity, therefore, would not be accounted for.
In conclusion, we find high rates of cardiovascular disease
risk factors among women veterans in middle adulthood, with
an apparent earlier emergence of disease among younger
cohorts. This will likely translate to a significant burden of
CVDwith associated suffering, healthcare costs, and mortality
in the future. The VA already supports sex-specific quality
improvement measures and is promoting efforts to increase
military women’s awareness of CVD through partnership with
the AHA’s “Go Red for Women” campaign. Future research
can help to understand what additional strategies to reduce the
risk of CVD in women veterans might be most effective.
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Figure 2. Prevalence of CVD risk factors in women veterans by age from 2000–2010*†‡. *For this analysis, the population of women was
restricted to those who received VA care in both FY2000 and FY2010. †Plots are smoothed. Lines represent connections between annual
rates. ‡Annual rates were derived as follows: in the restricted population, prevalence of risk factors was calculated in FY2000 and FY2010.
In women without the factor in FY2000, the cumulative annual incidence was calculated as the proportion of those with the factor during
that year from among those without it in the prior year. This was added to the baseline prevalence from FY2000 to estimate the period
prevalence for FY2000–2001. This process was repeated for each year between FY2000 and FY2010, calculating incidence proportion for
each year in those without the factor in prior years and adding it to the period prevalence from the prior year.
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